Neurovascular device company Imperative Care (Campbell, Calif.) said today that it has completed the initial closing of an $85 million Series C financing round to support the commercial launch of its portfolio. The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. Existing investors Ascension Ventures, Delos Capital, Rock Springs […]
Bain raises $900m for new life science fund
Bain Capital reportedly raised $900 million for its second life sciences fund and said it would pony up 20% of its own capital for the fund, aiming to back private companies on the cusp of going public and late-stage pharma concerns in need of commercial infrastructure. The fund plans to deploy investments of $20 million […]
Bain Capital raises $720m life sciences fund
Bain Capital said today that it raised $720 million for its 1st investment fund focused exclusively on the life sciences sector. “We are excited by some of the long-term secular trends in the life sciences space,” Bain Capital Life Sciences managing director Adam Koppel said. “Big pharma is increasingly outsourcing R&D at the same time as many new […]
Stryker to pay $1.3B for Physio-Control
Stryker (NYSE:SYK) said today that it agreed to pay $1.28 billion to Bain Capital for automated external defibrillator maker Physio-Control. Medtronic (NYSE:MDT) sold Physio-Control to Bain for $478 million in January 2012. The all-cash deal, slated to close at the beginning of the 2nd quarter, is expected to add slightly to Kalamazoo, Mich.-based Stryker’s adjusted earnings […]
Bidding war heats up for Toshiba Medical
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking outside investors to buy a stake in the healthcare business amid laying off nearly 7,000 workers, wants to focus on its core nuclear energy and chip businesses. Private equity shops KKR and Bain […]
CRM: BSX’s gain is STJ’s loss | Medtech Wall Street news for the week of March 23, 2015
ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A
Philips mulls 2016 IPO for lighting biz as bidding war heats up
ZMH to float $7.7B debt to acquire Biomet | The week in medtech M&A
Private equity shops battle for Philips’ legacy lighting biz
Report: Private equity giants vie for Johnson & Johnson’s Ortho Clinical Diagnostics biz
